PAMA - G2 Intelligence

New Rules for CDLTs that Aren’t ADLTs Take Effect Jan. 1

by Glenn S. Demby | Oct 30, 2021 | Articles, Essential, Lab Compliance Advisor, Reimbursement-lca

...

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

New Reporting Rules for CDLTs that Aren’t ADLTs Take Effect in January 2022

by Glenn S. Demby | Oct 19, 2021 | Articles, National Lab Reporter

...

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

OIG Work Plan Targets Medicare Part B Billing & Payment of Lab Tests

by Glenn S. Demby | Jun 28, 2021 | Articles, Essential, National Lab Reporter, OIG-nir, Reimbursement-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

ACLA Keeps the Pressure on CMS by Appealing Dismissal of PAMA Lawsuit

by Glenn S. Demby | Jun 28, 2021 | Articles, CMS-lir, Essential, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

Labs Lose a Battle But May Win the War Over Market-Based Pricing

by Glenn S. Demby | May 10, 2021 | Blog, News, Open Content

In its crusade to get CMS to fix its warped Protecting Access to Medicare Act of 2014 (PAMA) market-based Medicare Part B pricing scheme, the lab industry lost a battle but may still end up winning the war. Here’s a rundown of the rollercoaster PAMA developments and...

New Rules for CDLTs that Aren’t ADLTs Take Effect Jan. 1

Subscribe to View

New Reporting Rules for CDLTs that Aren’t ADLTs Take Effect in January 2022

Subscribe to View

OIG Work Plan Targets Medicare Part B Billing & Payment of Lab Tests

Subscribe to View

ACLA Keeps the Pressure on CMS by Appealing Dismissal of PAMA Lawsuit

Subscribe to View

Labs Lose a Battle But May Win the War Over Market-Based Pricing

Log In